HHS Secretary Alex Azar called the actions stemming from the administration’s drug blueprint so far “the tip of the iceberg,” while unveiling a department analysis that shows an overall drop in brand-name drug price increases and more price cuts.
100 days in, Azar says drug blueprint has helped curb prices
